Nasdaq · CIK 0001642380
IMDX Oncocyte Corp
Insider trading from SEC Form 4. Last filing Mar 28, 2025. Close $3.37 on Oct 9, 2026, +32% from the 52-week low and -60% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Price and insider trades, last year
IMDXOct 9, 2026 · close 3.37
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Oncocyte Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | Andrea S. James Chief Financial Officer buy | $200k 97,561 shares | +182% | - | |
| 50Moderate | Broadwood Partners, L.p. owner buy | $11M 5,165,695 shares | +83% | - | |
| 30Weak | Patrick W Smith owner buy | $192k 90,219 shares | +5% | - | |
| 31Weak | Andrew Arno director buy | $26k 12,500 shares | +18% | - | |
| 38Weak | Andrea S. James Chief Financial Officer buy | $46k 20,000 shares | +59% | - |
Transactions
The last 11 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Andrea S. James Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +113,207 | $0.00 | $0 | 113,207 | Mar 28, 2025 |
| Feb 7, 2025 | Andrea S. James Chief Financial Officer | POpen-market purchase Common Stock, no par value | +97,561 | $2.05 | $200k | 151,231 | Feb 11, 2025 |
| Feb 6, 2025 | Broadwood Partners, L.p. owner | POpen-market purchase Common Stock, no par value | +660,207 | $2.05 | $1.4M | 6,904,612 | Feb 10, 2025 |
| Feb 6, 2025 | Broadwood Partners, L.p. owner | POpen-market purchase Common Stock, no par valueindirect: Footnote | +0 | $0.00 | $0 | 6,904,612 | Feb 10, 2025 |
| Feb 6, 2025 | Broadwood Partners, L.p. owner | POpen-market purchase Common Stock, no par value | +4,505,488 | $2.05 | $9.2M | 11,410,100 | Feb 10, 2025 |
| Feb 6, 2025 | Broadwood Partners, L.p. owner | POpen-market purchase Common Stock, no par valueindirect: Footnote | +0 | $0.00 | $0 | 11,410,100 | Feb 10, 2025 |
| Dec 26, 2024 | Patrick W Smith owner | POpen-market purchase Common Stock, no par valueindirect: See footnote | +90,219 | $2.13 | $192k | 1,773,903 | Dec 27, 2024 |
| Dec 26, 2024 | Andrew Arno director | POpen-market purchase Common Stock, no par value | +12,500 | $2.11 | $26k | 81,554 | Dec 26, 2024 |
| Dec 5, 2024 | Andrea S. James Chief Financial Officer | POpen-market purchase Common Stock, no par value | +20,000 | $2.29 | $46k | 53,670 | Dec 9, 2024 |
| Oct 11, 2024 | Andrea S. James Chief Financial Officer | AGrant or award Options to Purchase Common Stockderivative | +200,000 | $0.00 | $0 | 200,000 | Oct 15, 2024 |
| Oct 11, 2024 | Andrea S. James Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +100,000 | $0.00 | $0 | 100,000 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Andrew Arnodirector
- Broadwood Partners, L.p.owner, director
- Andrea S. JamesChief Financial Officer
- Patrick W Smithceo, officer, director, owner
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.